Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy

Sonja Tattermusch, Jason A. Skinner, Damien J. Chaussabel, Jacques Banchereau, Matthew P. Berry, Finlay W. McNab, Anne O'Garra, Graham P. Taylor, Charles R M Bangham

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that persists lifelong in the host. In ~4% of infected people, HTLV-1 causes a chronic disabling neuroinflammatory disease known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The pathogenesis of HAM/TSP is unknown and treatment remains ineffective. We used gene expression microarrays followed by flow cytometric and functional assays to investigate global changes in blood transcriptional profiles of HTLV-1-infected and seronegative individuals. We found that perturbations of the p53 signaling pathway were a hallmark of HTLV-1 infection. In contrast, a subset of interferon (IFN)-stimulated genes was over-expressed in patients with HAM/TSP but not in asymptomatic HTLV-1 carriers or patients with the clinically similar disease multiple sclerosis. The IFN-inducible signature was present in all circulating leukocytes and its intensity correlated with the clinical severity of HAM/TSP. Leukocytes from patients with HAM/TSP were primed to respond strongly to stimulation with exogenous IFN. However, while type I IFN suppressed expression of the HTLV-1 structural protein Gag it failed to suppress the highly immunogenic viral transcriptional transactivator Tax. We conclude that over-expression of a subset of IFN-stimulated genes in chronic HTLV-1 infection does not constitute an efficient host response but instead contributes to the development of HAM/TSP.

Original languageEnglish
Article numbere1002480
JournalPLoS Pathogens
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 2012
Externally publishedYes

Fingerprint

Tropical Spastic Paraparesis
Human T-lymphotropic virus 1
Systems Biology
Interferons
Spinal Cord Diseases
Virus Diseases
Leukocytes
Viral Structural Proteins
Interferon Type I
Trans-Activators
Retroviridae
Genes
Multiple Sclerosis

ASJC Scopus subject areas

  • Microbiology
  • Parasitology
  • Virology
  • Immunology
  • Genetics
  • Molecular Biology

Cite this

Tattermusch, S., Skinner, J. A., Chaussabel, D. J., Banchereau, J., Berry, M. P., McNab, F. W., ... Bangham, C. R. M. (2012). Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathogens, 8(1), [e1002480]. https://doi.org/10.1371/journal.ppat.1002480

Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. / Tattermusch, Sonja; Skinner, Jason A.; Chaussabel, Damien J.; Banchereau, Jacques; Berry, Matthew P.; McNab, Finlay W.; O'Garra, Anne; Taylor, Graham P.; Bangham, Charles R M.

In: PLoS Pathogens, Vol. 8, No. 1, e1002480, 01.2012.

Research output: Contribution to journalArticle

Tattermusch, S, Skinner, JA, Chaussabel, DJ, Banchereau, J, Berry, MP, McNab, FW, O'Garra, A, Taylor, GP & Bangham, CRM 2012, 'Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy', PLoS Pathogens, vol. 8, no. 1, e1002480. https://doi.org/10.1371/journal.ppat.1002480
Tattermusch, Sonja ; Skinner, Jason A. ; Chaussabel, Damien J. ; Banchereau, Jacques ; Berry, Matthew P. ; McNab, Finlay W. ; O'Garra, Anne ; Taylor, Graham P. ; Bangham, Charles R M. / Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. In: PLoS Pathogens. 2012 ; Vol. 8, No. 1.
@article{040ad0cec96f453aa881a9c4da07ec54,
title = "Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy",
abstract = "Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that persists lifelong in the host. In ~4{\%} of infected people, HTLV-1 causes a chronic disabling neuroinflammatory disease known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The pathogenesis of HAM/TSP is unknown and treatment remains ineffective. We used gene expression microarrays followed by flow cytometric and functional assays to investigate global changes in blood transcriptional profiles of HTLV-1-infected and seronegative individuals. We found that perturbations of the p53 signaling pathway were a hallmark of HTLV-1 infection. In contrast, a subset of interferon (IFN)-stimulated genes was over-expressed in patients with HAM/TSP but not in asymptomatic HTLV-1 carriers or patients with the clinically similar disease multiple sclerosis. The IFN-inducible signature was present in all circulating leukocytes and its intensity correlated with the clinical severity of HAM/TSP. Leukocytes from patients with HAM/TSP were primed to respond strongly to stimulation with exogenous IFN. However, while type I IFN suppressed expression of the HTLV-1 structural protein Gag it failed to suppress the highly immunogenic viral transcriptional transactivator Tax. We conclude that over-expression of a subset of IFN-stimulated genes in chronic HTLV-1 infection does not constitute an efficient host response but instead contributes to the development of HAM/TSP.",
author = "Sonja Tattermusch and Skinner, {Jason A.} and Chaussabel, {Damien J.} and Jacques Banchereau and Berry, {Matthew P.} and McNab, {Finlay W.} and Anne O'Garra and Taylor, {Graham P.} and Bangham, {Charles R M}",
year = "2012",
month = "1",
doi = "10.1371/journal.ppat.1002480",
language = "English",
volume = "8",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy

AU - Tattermusch, Sonja

AU - Skinner, Jason A.

AU - Chaussabel, Damien J.

AU - Banchereau, Jacques

AU - Berry, Matthew P.

AU - McNab, Finlay W.

AU - O'Garra, Anne

AU - Taylor, Graham P.

AU - Bangham, Charles R M

PY - 2012/1

Y1 - 2012/1

N2 - Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that persists lifelong in the host. In ~4% of infected people, HTLV-1 causes a chronic disabling neuroinflammatory disease known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The pathogenesis of HAM/TSP is unknown and treatment remains ineffective. We used gene expression microarrays followed by flow cytometric and functional assays to investigate global changes in blood transcriptional profiles of HTLV-1-infected and seronegative individuals. We found that perturbations of the p53 signaling pathway were a hallmark of HTLV-1 infection. In contrast, a subset of interferon (IFN)-stimulated genes was over-expressed in patients with HAM/TSP but not in asymptomatic HTLV-1 carriers or patients with the clinically similar disease multiple sclerosis. The IFN-inducible signature was present in all circulating leukocytes and its intensity correlated with the clinical severity of HAM/TSP. Leukocytes from patients with HAM/TSP were primed to respond strongly to stimulation with exogenous IFN. However, while type I IFN suppressed expression of the HTLV-1 structural protein Gag it failed to suppress the highly immunogenic viral transcriptional transactivator Tax. We conclude that over-expression of a subset of IFN-stimulated genes in chronic HTLV-1 infection does not constitute an efficient host response but instead contributes to the development of HAM/TSP.

AB - Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that persists lifelong in the host. In ~4% of infected people, HTLV-1 causes a chronic disabling neuroinflammatory disease known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The pathogenesis of HAM/TSP is unknown and treatment remains ineffective. We used gene expression microarrays followed by flow cytometric and functional assays to investigate global changes in blood transcriptional profiles of HTLV-1-infected and seronegative individuals. We found that perturbations of the p53 signaling pathway were a hallmark of HTLV-1 infection. In contrast, a subset of interferon (IFN)-stimulated genes was over-expressed in patients with HAM/TSP but not in asymptomatic HTLV-1 carriers or patients with the clinically similar disease multiple sclerosis. The IFN-inducible signature was present in all circulating leukocytes and its intensity correlated with the clinical severity of HAM/TSP. Leukocytes from patients with HAM/TSP were primed to respond strongly to stimulation with exogenous IFN. However, while type I IFN suppressed expression of the HTLV-1 structural protein Gag it failed to suppress the highly immunogenic viral transcriptional transactivator Tax. We conclude that over-expression of a subset of IFN-stimulated genes in chronic HTLV-1 infection does not constitute an efficient host response but instead contributes to the development of HAM/TSP.

UR - http://www.scopus.com/inward/record.url?scp=84857497003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857497003&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1002480

DO - 10.1371/journal.ppat.1002480

M3 - Article

VL - 8

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 1

M1 - e1002480

ER -